Skip to content

Bioalmanac

Pancragen

Lys-Glu-Asp-Trp · KEDW peptide · Pancragen bioregulator

Preclinical

Status reviewed 18 Aug 2026

The pancreas peptide, sold on blood sugar and pancreatic function. Of everything in this family it is the one whose target market makes the absence of evidence most dangerous.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C. Do not freeze once mixed.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Reconstitution — 20 mg vial, 2000 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL20 mg/mL0.1 mL10 units10
2 mL10 mg/mL0.2 mL20 units10
3 mL6.667 mg/mL0.3 mL30 units10
5 mL4 mg/mL0.5 mL50 units10

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Course described in community sources1000–2000 mcgDaily for a 10-day course, repeated a few times a yearCommunity practice

When to stop

  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
  • An injection site that becomes hot, spreading or produces pus.
  • Any new or unexplained symptom you would ordinarily see a doctor about.

Not approved for human use in the United States, the European Union or the United Kingdom. Some peptides in this family are registered in Russia as supplements or medicines. Pancragen is sold elsewhere as a research chemical.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/pancragen

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.